20 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.

Stony Brook University
Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.

Stony Brook University
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase.

Stony Brook University
Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus.

Stony Brook University
Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands.

Stony Brook University
Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.

Stony Brook University
Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.

Stony Brook University
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Stony Brook University
Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.

Stony Brook University
Inhibition of mammalian target of rapamycin signaling by 2-(morpholin-1-yl)pyrimido[2,1-alpha]isoquinolin-4-one.

Stony Brook University
Truxillic acid monoamides as fatty acid binding protein 5 inhibitors.

Stony Brook University
Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy.

Stony Brook University
Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy.

Stony Brook University
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity.

Stony Brook University
New Frontiers in Druggability.

Stony Brook University
SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.

Stony Brook University
4-piperidinyl compounds for use as tankyrase inhibitors

Novartis
Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK

Medical Research Council Technology
New, potent P1/P2-morpholinone-based HIV-protease inhibitors.

Glaxosmithkline